MYCN and neuroblastoma: The intersection of the most differentially overexpressed genes in tumors with the highest MYCN expression and genes predicted to be located in the plasma membrane resulted in 14 potential cell-surface targets in MYCN amplified neuroblastoma tumors, 11 of which have TSS-proximal E-boxes.